DEXAMETHASONE OR CYCLOSPORINE-A SUPPRESS MAST CELL-LEUKOCYTE CYTOKINECASCADES - MULTIPLE MECHANISMS OF INHIBITION OF IGE-DEPENDENT AND MAST-CELL-DEPENDENT CUTANEOUS INFLAMMATION IN THE MOUSE
Bk. Wershil et al., DEXAMETHASONE OR CYCLOSPORINE-A SUPPRESS MAST CELL-LEUKOCYTE CYTOKINECASCADES - MULTIPLE MECHANISMS OF INHIBITION OF IGE-DEPENDENT AND MAST-CELL-DEPENDENT CUTANEOUS INFLAMMATION IN THE MOUSE, The Journal of immunology, 154(3), 1995, pp. 1391-1398
In allergic diseases, exposure of sensitized subjects to allergen indu
ces the activation of tissue mast cells that results in an immediate-t
ype hypersensitivity response and, in some individuals, a late phase r
esponse. We previously have reported that the neutrophil infiltration
associated with IgE-dependent cutaneous inflammation in mice is mast c
ell-dependent and that TNF-alpha contributes significantly to this res
ponse. We report here that either dexamethasone or cyclosporin A can i
nhibit mouse mast cell TNF-alpha production in vitro, and that these a
gents also can significantly suppress the tissue swelling and leukocyt
e infiltration associated with two forms of TNF-alpha-associated infla
mmation in vivo: the entirely IgE- and mast cell-dependent inflammatio
n at sites of passive cutaneous anaphylaxis reactions and the entirely
TNF-alpha-dependent inflammation that is elicited by the direct intra
dermal injection of recombinant mouse TNF-alpha. Taken together, our i
n vitro and in vivo findings in mice indicate that dexamethasone or cy
closporin A can have at least three actions that interfere with the pa
thogenesis of IgE, mast cell-, and cytokine-dependent inflammatory rea
ctions: suppression of the IgE-dependent increase in TNF-alpha mRNA by
mast cells, inhibition of the IgE-dependent production of TNF-alpha p
rotein by mast cells, and diminution of the responsiveness of target c
ells to TNF-alpha. Our findings in mice raise the possibility that sim
ilar actions of these agents in humans may account for some of the cli
nical efficacy of corticosteroids and cyclosporin A in allergic diseas
es.